| Financial Year |
March 31 2023 |
| Monetary Funds |
4,299,143,455.55 |
| Held-for-trading Financial Assets |
901,291,806.67 |
| Notes Receivable |
193,017,602.65 |
| Accounts Receivable |
3,762,230,443.53 |
| Advances to Suppliers |
122,769,492.22 |
| Other Receivables |
133,870,647.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,616,978,170.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
389,007,974.95 |
| Total Current Assets |
13,641,139,891.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,534,632,108.85 |
| Investment Properties |
158,610,099.92 |
| Fixed Assetes |
1,586,017,459.64 |
| Under-construction Projects |
112,602,043.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
279,029.55 |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
376,375,281.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
724,086.98 |
| Deferred Income Tax Assets |
383,888,166.37 |
| Other Non-Current Assets |
83,337,216.04 |
| Sub-Total of Non-Current Assets |
4,401,048,051.78 |
| Total Assets |
18,042,187,942.94 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,745,418,548.75 |
| Accounts Payable |
3,188,513,611.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,184,172.32 |
| Taxes Payable |
18,898,206.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,200,157,129.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,104,695.10 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
8,616,269,981.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
356,300,355.37 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
17,170,567.92 |
| Sub-Total of Non-Current Liabilities |
843,638,362.97 |
| Total Liabilities |
9,459,908,344.45 |
| Paid-In Capital(Or Share Stock) |
2,000,000,000.00 |
| Capital Surplus |
617,955,067.16 |
| Surplus Reserve |
935,991,727.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,723,507,958.74 |
| Minority Stockholder's Interest |
290,489,692.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,291,789,905.53 |
| Owner's Equity（Stockholder's Equity） |
8,582,279,598.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,042,187,942.94 |
